Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EPOAY | CNC |
|---|---|---|
| Price | $26.46 | $64.30 |
| Change today | ▲ 0.68% | ▲ 2.08% |
| Market cap | $31.77B | $31.76B |
| Return, 3 months | -0.4% | -2.8% |
| Return, year to date | +18.1% | +56.3% |
| Return, 1 year | +18.4% | +70.8% |
| P/E (TTM) | 33.9 | -6.2 |
| P/B | 0.8 | 1.4 |
| P/E percentile vs own 5y | – | 3rd |
| Dividend yield | 1.54% | – |
| Revenue growth (YoY, latest qtr) | – | +9.9% |
| Net profit growth (YoY) | – | +519.7% |
| Gross margin | – | 7.8% |
| Operating margin | – | 0.8% |
| Net margin | – | -2.5% |
| Return on equity | – | -20.4% |
| Analyst target vs. price | – | +13.0% |
| Analyst buy share | – | 40% |
| RSI (14) | 51 | 51 |
| 30-day volatility | 32.2% | 31.5% |
| Max drawdown, 1 year | -23.4% | -32.7% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
